Mp54-05 evaluating intravesical nadofaragene firadenovec and immune checkpoint blockade combination therapy in bcg-unresponsive non-muscle-invasive bladder cancer: evidence from a phase 3 trial
Journal of Urology（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要